Background: Metabolic syndrome has long been recognized as a risk factor for coronary heart disease. However, the relationship between metabolic syndrome and type 2 diabetes mellitus and the independent contribution of metabolic syndrome remain unclear. This study was planned to evaluate the status of metabolic syndrome in type 2 diabetic population and the ability to predict type 2 diabetes mellitus in parallel with conventional stroke risk factors. Methods: A hospital-based descriptive observational study was conducted on 100 patients with type 2 diabetes mellitus who were selected using consecutive random sampling techniques. Patients were diagnosed through proper history taking, clinical examination, and necessary investigations. The outcome values were measured in anthropometric measurements, blood pressure, dyslipidemia, and blood glucose. Results: Among 100 patients with type 2 diabetes mellitus, 64% were females who were housewives (41%) with a significant difference (p < 0.001), and mean ± SD was 58 ± 12.24 yrs ranging 32–85 years. About 30% had a positive family history of type 2 diabetes mellitus and 28% tobacco abuse. Of the total, 31% of the patients had high blood pressure, and 28% had low HDL with a significant difference (p < 0.001), but 46% had high triglyceride levels, which was not significant. More than half (53.12%) of females showed central obesity, while only 16.67% had central obesity among males, with a significant difference (p = 0.04) in both sexes. There was a high frequency of metabolic syndrome in patients with type 2 diabetes mellitus (68%) with a significant difference; 48% were female and 20 % were male. In patients with metabolic syndrome, central obesity was found in 36 (52.94%) patients where females were predominantly affected (32, 88.89%); hypertension found in 28 (4118%) patients where males were the predominantly affected (16, 57.14%) patients’ hypertriglyceridemia found in 44 (64.70%) patients, where females were the predominantly affected (26, 59.09%) patients; low HDL was found in 22 (32.35%) patients where females were the predominantly affected patients (16, 72.73%). Conclusion: The frequency of metabolic syndrome was more than double in women (48%). Central obesity and low HDL were significantly more prevalent in women than men, whereas hypertension was significant in men. Thus, it would be reasonable to conclude that women are more likely to suffer from metabolic syndrome from cardiovascular morbidity and mortality.
Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004; 27(11):2676-81. https://doi.org/10.2337/diacare.27.11.2676
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735–52. https://doi.org/10.1161/circulationaha.105.169404
Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults – a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003;60(3):199-204. https://doi.org/10.1016/s0168-8227(03)00060-3
Reddy KS, Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation. 1998; 97(6): 596-601. https://doi.org/10.1161/01.cir.97.6.596
DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14(3):173-94. https://doi.org/10.2337/diacare.14.3.173
Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab. 2004; 89(10):5013–20. https://doi.org/10.1210/jc.2004-0265
Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk Factors for Early Myocardial Infarction in South Asians Compared With Individuals in Other Countries. JAMA. 2007; 297 (3):286-94. https://doi.org/10.1001/jama.297.3.286
Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation. 2003; 108(13):1541-5. https://doi.org/10.1161/01.cir.0000088845.17586.ec
Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, at al. Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2003; 34(7):1586-92. https://doi.org/10.1161/01.str.0000075294.98582.2f
Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000; 106(4):453-8. https://doi.org/10.1172/jci10762
Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, at al. Abdominal obesity and risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke. 2003; 34(7):1587-92. https://doi.org/10.1161/01.str.0000075294.98582.2f
Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, et al. Abdominal adiposity and coronary heart disease in women. JAMA. 1998; 280(21):1843-48. https://doi.org/10.1001/jama.280.21.1843
American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2011;34(Supplement 1): S62-S69. https://doi.org/10.2337/dc11-s062
Lohman TG, Roche AF, Martorell R. Anthropometric Standardisation Reference Manual. Champaign: Human Kinetics Books; 1988.
Clinical Guidlines on the identification, Evaluation and treatment of overweight and obesity in adults .National institute of health; National heart, lung and blood institute; US. department of Health and human services: public health services;1998.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association, et al. Definition of metabolic syndrome: report of the National, Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-438. https://doi.org/10.1161/01.CIR.0000111245.75752.C6
Tanweer S, Illahi Y, Amatya B, Naeem A, Zia Tareen F. Frequency of the Metabolic Syndrome In Type 2 Diabetic Subjects Attending The Diabetes Clinic Of Nishtar Medical College And Hospital. Ann Punjab Med college. 2011; 5(1): 53-58. https://doi.org/10.29054/apmc/2011.533
Imam SK, Shahid SK, Hassan A, Alvi Z. Frequency of the metabolic syndrome in type2 diabetic subjects attending the diabetes clinic of tertiary care hospital. J Pak Med Assoc. 2007;57(5):239-42. [Accessed 2022 Feb 23]. Available from: http://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.506.4277&rep=rep1&type=pdf
Khan UK, Dipta TF, Faruque MO, Sarder K, Sultana S, Nahar Q. Prevalence of Metabolic Syndrome in Diabetic Patient. J Banglad College Physic Surg. 2012; 30(2)-85-90. https://doi.org/10.3329/jbcps.v30i2.11409
Barbaro G, Barbarini G. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk. Chemotherapy. 2006; 52(4):161-5. https://doi.org/10.1159/000093034
Agrawal V, Bansal M, Mehrotra R, Hansa G, Kasliwal RR. Prevalence of Metabolic Syndrome and its Individual Components in an Asymptomatic Urban North Indian Population. Indian Heart J. 2003; 5.
Chuang SY, Chen CH, Tsai ST, Chou P. Clinical identification of the metabolic syndrome in Kinmen. Acta Cardiol Sin. 2002; 18:16-23.
Mohsin A, Zafar J, Nisar Y, Imran SM, Zaheer K, Khizar B, et al. Frequency of the metabolic syndrome in adult type2 diabetics presenting to Pakistan Institute of Medical Sciences. J pak Med Assoc. 2007: 57(5):235-9. [Accessed 2022 Feb 23]. Available from: https://web.archive.org/web/20170809030224id_/http://jpma.org.pk/PdfDownload/1089.pdf
Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8. https://doi.org/10.1161/01.cir.0000111245.75752.c6
Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 2000; 105(3):271-8. https://doi.org/10.1172/jci7901
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 MSI Tipu Chowdhury, Basher Atiquzzaman, Mohammad Afjal Hossain, Maheen Kabir, Tanvir Adnan, Marufa Yasmin